Finance

Beta
Lists
INNPF:OTCMKTS
Innocan Pharma Corp
USD 2,50
0,00%
(0,00) 1D
27 Mei, 10:50:05 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INNPF...
Mkt. cap
16,26 m
Avg. vol.
39,00
Volume
0,00
52-wk high
USD 14,26
52-wk low
USD 2,50
Beta
0,66
Shares outstanding
4,50 m
No. of employees
8
Mkt. cap
16,26 m
Avg. vol.
39,00
Volume
0,00
52-wk high
USD 14,26
52-wk low
USD 2,50
Beta
0,66
Shares outstanding
4,50 m
No. of employees
8
News stories
From sources across the web
About Innocan Pharma Corp
CEO-
Employees8
Founded2017
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
7,01 m
6,82 m
4,99 m
6,46 m
Cost of goods sold
811,00 k
631,00 k
558,00 k
575,00 k
Cost of revenue
811,00 k
631,00 k
558,00 k
575,00 k
Research and development expenses
176,00 k
415,00 k
161,00 k
184,00 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,62 m
6,99 m
5,19 m
6,49 m
Operating expense
5,80 m
7,41 m
5,35 m
6,68 m
Total operating expenses
6,61 m
8,04 m
5,91 m
7,25 m
Operating income
396,00 k
-1,22 m
-922,00 k
-786,00 k
Other non operating income
-327,00 k
-200,00 k
1,93 m
7,00 k
EBT including unusual items
-109,00 k
-1,43 m
1,59 m
-822,00 k
EBT excluding unusual items
-17,00 k
-1,30 m
1,00 m
-786,00 k
Income tax expense
206,00 k
220,00 k
-262,00 k
64,00 k
Effective tax rate
-188,99%
-15,36%
-16,45%
-7,79%
Other operating expenses
-
-
-
-
Net income
-590,00 k
-1,95 m
2,00 m
-972,00 k
Net profit margin
-8,42%
-28,54%
40,00%
-15,03%
Earnings per share
-
-
-
-
Interest and investment income
-
7,00 k
-
-
Interest expense
-4,00 k
-
-3,00 k
-7,00 k
Net interest expenses
-4,00 k
7,00 k
-3,00 k
-7,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
405,00 k
-1,21 m
-910,00 k
-778,00 k
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more